CD4 and B-cell non-Hodgkin lymphoma: High serum IgM levels associated with high smB cells has been linked to higher incidence of B-cell lymphoma’s in CVID17,39, while CD4+ T-lymphocytopenia may add on susceptibility risk of opportunistic infections in a subset of CVID patients.